Role Summary
The Global Head, Immunology Franchise Medical Strategy and Innovation will lead the medical strategy for the Next Generation Immunology portfolio, aligning with R&D and Commercial. The role requires a unified global strategy on the science of the immunology pipeline to ensure consistent messaging, resources, and tactics across priority molecules and disease areas. You will lead the development and implementation of above-TA medical strategy in areas of insight development, evidence generation, scientific communications, and scientific engagement, in full alignment with Commercial and R&D strategies to optimize the Immunology portfolio. The role also leads medical strategic planning, drives cross-functional and cross-regional collaboration, and delivers value by optimizing launch capabilities, dynamic resource allocation, and a digital transformation plan for Medical. Location: Cambridge, MA; Morristown, NJ.
Responsibilities
- Develop and optimize the medical portfolio strategy, ensuring all initiatives align with business priorities, scientific advancements, and patient needs
- Play a leading role in defining cross-TA and cross-portfolio strategic planning including integrated Evidence Generation Plan (iEGP); integrated Scientific Communication Plan (iSCP); Insight Generation Plan (IGP) and integrated Scientific Engagement Plan (iSEP) to ensure optimal investment and impact-drive decision making for the franchise
- Lead medical strategic planning process across TAs, provide governance to ensure consistency and efficiency
- Support the prioritization of medical activities and resources, ensuring optimal alignment across global, regional, and key markets
- Collaborate closely with Global Medical Franchise Portfolio Strategy team along with counterparts from other franchises and key markets to ensure alignment and connection to the Specialty Care GBU and overall Sanofi company strategy and drive impactful communications with and beyond Medical
- Foster collaboration between internal functions and external partnerships, ensuring alignment across R&D, Medical, and Commercial to ensure effective communication, effective decision-making, and consensus building where required
- Identify, track, and assess external AI advancements, build relationships with domain experts, and report key innovations to inform long-term strategy and governance
- Lead and shape the above-TA inflammation scientific narrative for the franchise in alignment with portfolio strategies and embed it into asset and medical initiatives
- In close collaboration with GTMC partners, identify, build and strengthen medical capabilities in launch excellence across TAs. Develop framework, KPIs, tracking tools and resources to ensure global consistency in launch execution in priority markets
- Drive digital transformation in Medical by integrating cutting-edge technologies and creating an AI-enabled ecosystem accessible to the full medical organization for insights gathering, evidence generation and scientific communications and engagement
Qualifications
- Advanced scientific degree (MD, PhD, PharmD) required
- Minimum 15 yearsβ experience in the pharmaceutical and/or biotechnology industry combined with a strong focus on immunology or related field
- Significant management experience across therapeutic areas (TAs) in immunology or related field
- Proven ability to work effectively in a matrixed, global environment, collaborating across multiple geographies, functions, and business units
- Strong leadership and influence skills, with a track record of successfully driving initiatives and engaging with senior stakeholders
- Expertise in medical affairs strategy, portfolio management, and stakeholder engagement
- Deep understanding of medical affairs strategy, lifecycle management, stakeholder engagement, and evidence generation
- Expertise in KOL/DOL engagement frameworks, medical governance, and launch excellence strategies
- Ability to adapt to a rapidly evolving healthcare landscape and drive change management